{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:07:06Z","timestamp":1791025626532,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008664","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T00:00:00Z","timestamp":1334707200000}}],"reference-count":66,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008664.pub2","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T19:54:07Z","timestamp":1334260447000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Thalidomide for managing cancer cachexia"],"prefix":"10.1002","volume":"2021","author":[{"given":"Joanne","family":"Reid","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery; Queen's University Belfast; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moyra","family":"Mills","sequence":"additional","affiliation":[{"name":"Northern Health and Social Care Trust; Antrim UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie M","family":"Cantwell","sequence":"additional","affiliation":[{"name":"Centre for Public Health; Queen's University Belfast; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris R","family":"Cardwell","sequence":"additional","affiliation":[{"name":"Centre for Public Health; Queen's University Belfast; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam J","family":"Murray","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology and Health Services Research Group; Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Centre for Public Health; Queen's University Belfast; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"key":"10.1002\/14651858.CD008664.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gut.2004.047563","article-title":"Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial","volume":"54","author":"Gordon","year":"2005","journal-title":"GUT"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1634\/theoncologist.2009-0153","article-title":"Randomised phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia","volume":"15","author":"Mantovani","year":"2010","journal-title":"The Oncologist"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0003|cit3","first-page":"1","article-title":"Poor tolerability of thalidomide in end-stage oesophageal cancer","volume":"DOI: 10.1111\/j.","author":"Wilkes","year":"2011","journal-title":"European Journal of Cancer Care"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0004|cit4","first-page":"609a, Abstract","article-title":"Thalidmode induced cessation of weight loss and improved sleep in advanced cancer patients with cachexia","volume":"19","author":"Boasberg","year":"2000","journal-title":"American Society Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD008664.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1023\/A:1008329821941","article-title":"Thalidomide in patients with cachexia due to terminal cancer: Preliminary report","volume":"10","author":"Bruera","year":"1999","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1002\/14651858.CD008664.pub2-BIB0006|cit6","first-page":"490","article-title":"Thalidomide - Celgene Corporation","volume":"1","author":"Bruyn","year":"1998","journal-title":"Drugs"},{"issue":"1","key":"10.1002\/14651858.CD008664.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/026921630001400116","article-title":"Thalidomide for night sweats in patients with advanced cancer","volume":"12","author":"Calder","year":"2000","journal-title":"Palliative Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008664.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1183\/09031936.00136408","article-title":"Small studies: strengths and limitations","volume":"32","author":"Hachshaw","year":"2008","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD008664.pub2-BIB0009|cit9","first-page":"53","article-title":"Antocytokine approaches to the treatment of anorexia and cachexia","volume":"25","author":"Haslett","year":"1998","journal-title":"Seminars in Oncology"},{"issue":"3","key":"10.1002\/14651858.CD008664.pub2-BIB0010|cit10","first-page":"144","article-title":"New drugs potentially useful for the cachexia treatment in palliative care","volume":"8","author":"Herrera","year":"2001","journal-title":"Medicina Paliativa"},{"issue":"2","key":"10.1002\/14651858.CD008664.pub2-BIB0011|cit11","first-page":"154","article-title":"Palliative care from the beginning of treatment for advanced pancreatic cancer","volume":"11","author":"Lazenby","year":"2010","journal-title":"Journal of the Pancreas"},{"issue":"31","key":"10.1002\/14651858.CD008664.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1200\/JCO.2009.21.9733","article-title":"Randomised double blind placebo controlled trial of thalidomide in combination with gemcitabine and carboplatin in advanced non small cell lung cancer","volume":"27","author":"Lee","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD008664.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0609.2006.00774.x","article-title":"Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patients","volume":"78","author":"Martino","year":"2007","journal-title":"European Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD008664.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2036.2006.02758.x","article-title":"Thalidomide: an effective anabolic agent in gastrointestinal cancer cachexia","volume":"23","author":"Ockenga","year":"2006","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0169-5002(07)70143-5","article-title":"Malignant mesothelioma and cachexia. description of body composition changes in 27 patients receiving chemotherapy and\/or thalidomide","volume":"54","author":"Pavlakis","year":"2006","journal-title":"Lung cancer"},{"issue":"12","key":"10.1002\/14651858.CD008664.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.ejca.2006.05.018","article-title":"Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of thr5ee dosing schedules in patients with solid malignancies","volume":"42","author":"Sharma","year":"2006","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD008664.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/082585970802400309","article-title":"Thalidomide in the treatment of cancer cachexia","volume":"24","author":"Tassinari","year":"2008","journal-title":"Journal of Palliative Care"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0018|cit18","first-page":"171","article-title":"Thalidomide versus thalidomide with olanzapine and megestrol acetate in treatment of cachexia in gastro intestinal cancer: A randomised trial","volume":"18 Suppl 3","author":"Sanchetee","year":"2010","journal-title":"Support Cancer Care"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0019|cit19","unstructured":"The Role of Thalidomide in Reversing Cachexia in Patients with Oesophageal Cancer"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0020|cit20","unstructured":"The use of thalidomide as a treatment for cancer cachexia"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0021|cit21","unstructured":"Lenalidomide for Lean Body Mass and Muscle Strength in Inflammatory Cancer Cachexia Syndrome"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0022|cit22","first-page":"229","article-title":"Consensus on cachexia definitions","volume":"4","author":"Argiles","journal-title":"Journal of the American Medical Directors Association"},{"issue":"2","key":"10.1002\/14651858.CD008664.pub2-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004310.pub2","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","author":"Berenstein","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0024|cit24","unstructured":"British National Formulary British National Formulary 58 London British Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD008664.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.12968\/ijpn.1999.5.1.9933","article-title":"The problem of weakness in patients with advanced cancer","volume":"5","author":"Brown","year":"1999","journal-title":"International Journal of Palliative Nursing"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0026|cit26","volume-title":"Palliative Medicine: a case based manual","author":"Bruera","year":"1993"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0027|cit27","volume-title":"Cachexia-anorexia in cancer patients","author":"Bruera","year":"1996"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0022-5347(05)67023-1","article-title":"Phase III study of\u00a0paclitaxel and\u00a0cisplatin for advanced\u00a0urothelial cancer","volume":"164","author":"Burch","year":"2000","journal-title":"Journal of Urology"},{"issue":"3","key":"10.1002\/14651858.CD008664.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/MCO.0b013e3283455e21","article-title":"Cancer cachexia therapy","volume":"14","author":"Coss","year":"2011","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1191\/0269216304pm906ra","article-title":"Research Methodology: Cancer cachexia syndrome","volume":"18","author":"Dahele","year":"2004","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0031|cit31","first-page":"423","article-title":"Adiponectin and insulin resistance associated with endometrial cancer","volume":"2","author":"DeBoer","year":"2006","journal-title":"Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0032|cit32","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD008664.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004597.pub2","article-title":"Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia","author":"Dewey","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"62","key":"10.1002\/14651858.CD008664.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-med-061509-131248","article-title":"Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies","volume":"18","author":"Dodson","year":"2011","journal-title":"Annual Review of Medicine"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: principles and procedures","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1517\/13543784.12.7.1211","article-title":"Thalidomide: a new anticancer drug?","volume":"12","author":"Fanelli","year":"2003","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/gut.52.10.1479","article-title":"Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia","volume":"52","author":"Fearon","year":"2003","journal-title":"Gut"},{"issue":"6","key":"10.1002\/14651858.CD008664.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","article-title":"Cancer cachexia: Developing multimodal therapy for a multidimensional problem","volume":"44","author":"Fearon","year":"2008","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0043|cit43","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009] The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org 2009","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0044|cit44","first-page":"172","volume-title":"Cachexia-Anorexia in Cancer Patients","author":"Higginson","year":"1996"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0045|cit45","first-page":"72","article-title":"Cancer anorexia-cachexia syndrome","volume":"52","author":"Inui","year":"2002","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0046|cit46","first-page":"199","volume-title":"Evaluation of Chemotherapeutic Agents","author":"Karnofsky","year":"1949"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2036.2003.01457.x","article-title":"Oesophageal cancer and cachexia: the effect of short term treatment with thalidomide on weight loss and lean body mass","volume":"17","author":"Khan","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD008664.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-133-8-200010170-00015","article-title":"Cachexia","volume":"133","author":"Kolter","year":"2000","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD008664.pub2-BIB0049|cit49","first-page":"158","article-title":"Therapy Insight: cancer anorexia-cachexia syndrome-when all you can eat is yourself","volume":"2","author":"Laviano","year":"2005","journal-title":"Nature"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.1993.11.4.762","article-title":"Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and\/or cachexia","volume":"22","author":"Loprinzi","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0051|cit51","volume-title":"Topics in palliative care","author":"Ma","year":"1998"},{"issue":"12","key":"10.1002\/14651858.CD008664.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00520-009-0776-2","article-title":"Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility study","volume":"18","author":"Maddocks","year":"2010","journal-title":"Supportive Care in Cancer"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nut.2007.12.010","article-title":"Randomised phase III clinical trial of five different arms of treatment for patients with cancer cachexia: Intrim results","volume":"24","author":"Mantovani","year":"2008","journal-title":"Nutrition"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0054|cit54","first-page":"292","article-title":"Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia","volume":"14","author":"Mantovani","year":"2010","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0055|cit55","first-page":"1751","article-title":"Primary caregiver perceptions of intake cessation in patients who are terminally ill","volume":"24","author":"Meares","year":"1997","journal-title":"Oncology Nursing Forum"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1517\/14728210903369351","article-title":"Update on emerging drugs for cancer cachexia","volume":"14","author":"Murphy","year":"2009","journal-title":"Expert Opinion on Emerging Drugs"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Intreste Group (SIG) \"cachexia-anorexia in chronic wasting diseases\" and \"nutrition in geriatrics\"","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clinical Nutrition"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.mco.0000134363.53782.cb","article-title":"Cancer anorexia-cachexia syndrome","volume":"7","author":"Ramos","year":"2004","journal-title":"Current Opinion Clinical Nutrition and Metabolic Care"},{"issue":"5","key":"10.1002\/14651858.CD008664.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijnurstu.2008.10.012","article-title":"The experience of cancer cachexia: A qualitative study of advanced cancer patients and their family members","volume":"46","author":"Reid","year":"2009","journal-title":"International Journal of Nursing Studies"},{"issue":"4","key":"10.1002\/14651858.CD008664.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1188\/09.ONF.439-445","article-title":"Fighting over food: Patient and family understanding of cancer cachexia","volume":"36","author":"Reid","year":"2009","journal-title":"Oncology Nursing Forum"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/014860710002400252","article-title":"Time-dependent variation in weight and body composition in healthy adults","volume":"24","author":"Rosenbaum","year":"2000","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD008664.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpainsymman.2003.06.003","article-title":"Further validation of the multidimensional fatigue symptom inventory-short form","volume":"27","author":"Stein","year":"2004","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/gut.2004.053330","article-title":"Thalidomide and cancer cachexia: old problem, new hope?","volume":"54","author":"Stroud","year":"2005","journal-title":"Gut"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc927","article-title":"Cachexia in cancer patients","volume":"2","author":"Tisdale","year":"2002","journal-title":"Nature Reviews Cancer"},{"key":"10.1002\/14651858.CD008664.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiological Reviews"},{"issue":"3","key":"10.1002\/14651858.CD008664.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2036.2006.02738.x","article-title":"Thalidomide: an effective anabolic agent in gastrointestinal cancer cachexia","volume":"23","author":"Wilkes","year":"2006","journal-title":"Alimentary Pharmacology and Therapeutics"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008664.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T18:02:44Z","timestamp":1651687364000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008664.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,18]]},"references-count":66,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008664.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,18]]}}}